Catalyst Wire Dossier Catalyst Wire Dossier

Quofenix

delafloxacin meglumine · A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quofenix, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: EMA Authorised: Quofenix (delafloxacin meglumine) — A. Menarini Industrie Farmaceutiche Riunite s.r.l.

See pricing